Growth Metrics

Bruker (BRKR) Long-Term Investments (2023 - 2025)

Bruker filings provide 3 years of Long-Term Investments readings, the most recent being $114.7 million for Q4 2025.

  • On a quarterly basis, Long-Term Investments rose 0.97% to $114.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $114.7 million, a 0.97% increase, with the full-year FY2025 number at $114.7 million, up 0.97% from a year prior.
  • Long-Term Investments hit $114.7 million in Q4 2025 for Bruker, up from $113.6 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $114.7 million in Q4 2025 to a low of $81.0 million in Q4 2023.
  • Median Long-Term Investments over the past 3 years was $113.6 million (2024), compared with a mean of $103.1 million.
  • Biggest five-year swings in Long-Term Investments: skyrocketed 40.25% in 2024 and later increased 0.97% in 2025.
  • Bruker's Long-Term Investments stood at $81.0 million in 2023, then surged by 40.25% to $113.6 million in 2024, then rose by 0.97% to $114.7 million in 2025.
  • The last three reported values for Long-Term Investments were $114.7 million (Q4 2025), $113.6 million (Q4 2024), and $81.0 million (Q4 2023) per Business Quant data.